Photo By: Evan-Amos - Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=86913279
The newborn infant is susceptible to infection because of an immature immune system. Infections can be acquired in utero (congenital infection), during the intrapartum period, or postnatally.
Neonatal sepsis is one of the most significant causes of neonatal morbidity and mortality. It is defined as a systemic inflammatory response syndrome (SIRS) that occurs secondary to infection. SIRS is recognized by the presence of two or more of these signs/symptoms:
Hypothermia or fever
Tachypnea or hyperventilation
Tachycardia
High or low white blood cell count
Neonatal sepsis is classified into two patterns according to the time of presentation:
Early-onset sepsis is an invasive bacterial infection of the blood and/or CSF that occurs within the first 7 days of life.
Late-onset sepsis occurs at approximately 7 to 30 days of age.
Maternal
Low socioeconomic status
Late or no prenatal care
Poor nutrition
Substance abuse
Recent acquired sexually transmitted infection, untreated focal urinary infection (urinary tract, vaginal, or cervical, or systemic infection
Malnourishment
Intrapartum
Maternal Fever
Premature rupture of membranes
Chorioamnionitis
Prolonged labor
Preterm labor
Use of fetal scalp electrode
Neonatal
Multiple gestation
Male
Birth asphyxia
Meconium aspiration
Congenital anomalies of skin or mucous membranes
Metabolic disorders (e.g. galactosemia)
Low birth weight
Formula feeding
Prolonged hospitalization
Mechanical ventiliation
Umbilical artery catheterization or use of other vascular catheters
Earliest clinical signs of neonatal sepsis are nonspecific and include lethargy, poor feeding, and temperature instability, particularly hypothermia. The following laboratory studies are also used:
Cultures including blood, CSF, and urine
Fluids such as urine and CSF can be evaluated by counterimmunoelectrophoresis or latex agglutination to help identify the bacteria
Complete blood count (CBC)
Sedimentation rate
Cytokine assays
Nucleic acid amplification testing
Standard treatment for early-onset sepsis includes ampicillin and an aminoglycoside. Late-onset sepsis is treated with vancomycin and an aminoglycoside. Antepartum viral infection can be treated with antiviral. Breastfeeding or feeding the newborn expressed breast milk from the mother is encouraged.
Administering medications
Monitoring IV infusions
Taking precautions when performing treatments
Following isolation procedures
Suctioning is not recommended and can further compromise the infant’s immune status
Isolation procedures are implemented as indicated
Hand hygiene is the single most important measure in preventing the spread of infection. Follow standard precautions and guidelines for space, visitation, and general infection control in areas where newborns receive care.
Viral infections that are acquired perinatally can cause:
Stillbirth
Intrauterine infection
Congenital malformations
Acute disease
Chronic infection
Cytomegalovirus (CMV) is the most common congenital viral infection in the US. Clinical manifestations at birth can include:
Rash
Petechiae
Jaundice
Hepatosplenomegaly
IUGR
Microcephaly
Chorioretinitis
Intracerebral calcifications
CMV-associated sequelae:
Thrombocytopenia
Hepatitis
Chorioretinitis
Sensorineural hearing loss
Cognitive impairment
IUGR
Varicella (chickenpox) is an acute infectious disease caused by the varicella-zoster virus (VZV). When transmission to the fetus occurs during the first or early second trimester, congenital varicella can result in:
Fetal death
Limb hypoplasia
Damage to the CNS
Eye abnormalities
Perinatal varicella may cause generalized, pruritic, vesicular rash or only a few lesions. Complications can include pneumonia, CNS involvement, thrombocytopenia, and hepatitis (AAP, 2018). Neonatal varicella is treated with IV acyclovir. Seroimmune pregnant women exposed to active chickenpox can be given VariZIG.
Congenital rubella syndrome includes:
Cataracts or glaucoma
Hearing loss (the most common sign)
Cardiac defects (pulmonary artery stenosis, patent ductus arteriosus, or coarctation of the aorta)
Multiple other abnormalities may also be present, including:
Low birth weight
Microphthalmia
Hypotonia
Hepatosplenomegaly
Thrombocytopenic purpura
Dermatoglyphic abnormalities
Bony radiolucencies
Microcephaly
Brain wave abnormalities
Severe infection can result in fetal death
Perinatal transmission of hepatitis B virus (HBV) from an infected mother to her fetus usually occurs during the blood exposure that occurs during labor and birth. Transmission can also occur through breast milk. There is no specific treatment for acute HBV infection. Follow-up is essential to monitor for chronic liver disease. CDC recommends universal HBV immunization of all neonates prior to hospital discharge and subsequent completion of the recommended vaccine series. Infant born to a mother who is seropositive for HBV should receive HBV vaccine and hepatitis B immune globulin (HBIg) within 12 hours after birth and should complete the recommended vaccine series, followed by postvaccination serologic testing. If the mother’s HBV status is unknown when she is admitted to the birthing facility, she should have serologic testing. Her infant should receive the HBV vaccine within 12 hours after birth, and if she is seropositive, HBIg should be administered to the newborn as soon as possible.
Transmission of HIV from the mother to the fetus can occur transplacentally at various gestational ages. HIV-infected neonate is asymptomatic at birth. Early-onset illness (i.e., virus detected within 48 hours of birth) is attributed to prenatal infection. These infants develop opportunistic infections (Candida and Pneumocystis jiroveci pneumonia) and experience rapid progression of immunodeficiency that often results in death during the first 1 to 2 years of life. Remainder of infants seroconvert over a period of months to years. By 1 year of age majority of perinatally infected infants show signs of infection. Presenting signs and symptoms of HIV infection vary from severe immunodeficiency to nonspecific findings such as:
Growth failure
Parotitis
Recurrent or persistent upper respiratory tract infections
Lymphadenopathy
Hepatosplenomegaly are common
Fever
Chronic diarrhea
Chronic dermatitis
Interstitial pneumonitis
Persistent thrush
AIDS-defining opportunistic infections
Congenital infection is rare and is characterized by in utero destruction of normally formed organs, resulting in IUGR, microcephaly, hydranencephaly, chorioretinitis, and fetal death. In the majority of cases, HSV is transmitted from mother to neonate through viral shedding during labor and birth. Clinically, neonatal HSV infections are classified as:
Disseminated infection
CNS disease
Localized infection of the skin, eye, or mouth (SEM)
There can be overlap of symptoms from these categories. The majority of newborns infected with HSV have a localized infection affecting their skin, eyes, and/or mouth. Skin vesicles are often present at birth and tend to recur. Care management depends on maternal history. Cesarean birth is recommended for women with active genital lesions. All infants born by cesarean or vaginal birth to women with active lesions should be placed on contact precautions. Surface cultures and blood and surface polymerase chain reaction (PCR) for HSV, serum alanine transaminase (ALT) and CSF cell count, chemistries, and PCR for HSV are done 24 hours after birth. Treatment with acyclovir is started after the evaluation.
Enteroviruses include coxsackieviruses, echoviruses, and numbered enteroviruses. The most frequent mode of transmission to the neonate occurs during and after birth through contact with maternal blood, cervical or vaginal secretions, or fecal material. Symptoms include:
Fever
Irritability
Lethargy
Poor feeding
Rash
Respiratory symptoms
GI symptoms
Infection can be severe and include myocarditis, meningitis, respiratory distress, and hepatitis. No specific therapy is available. Intravenous immunoglobulin may be used in life-threatening situations or for the treatment of infections in immunocompromised clients.
Parvovirus B19 infection is well known in older children as erythema infectiosum (EI) or fifth disease. It's often called the “slapped cheek illness.” Clinical manifestations include fever, malaise, myalgia, and rash. Infection is transmitted by vertical transmission from mother to fetus, contact with respiratory tract secretions, and exposure to blood or blood products. During pregnancy, infection can result in miscarriage, fetal anemia, hydrops fetalis, IUGR, or stillbirth.
Pregnant women who contract influenza are at risk for complications, especially pulmonary problems. Newborns who become ill with influenza are at high risk for severe complications. If the mother has influenza infection during the intrapartum or immediate postpartum period, she should be separated from her newborn. Separation should continue until the mother has received antiviral medication for 48 hours, she is afebrile without antipyretics for longer than 24 hours, and she is capable of controlling her respiratory secretions and cough.
Zika virus is recognized as a mosquito-borne teratogen that can cause:
Fetal loss
Microcephaly
Serious neurologic defects
Microcephaly
Brain
Ocular
Optic nerve anomalies
Congenital contractures
Other neurologic problems:
Hearing loss
Swallowing dysfunction
Hypertonia
Hypotonia
Irritability
Tremors
COVID-19
Infants born to mothers who are positive for COVID-19 near the time of delivery are at the highest risk of infection. Newborn death directly attributed to COVID-19 is rare, but maternal infection is more associated with commpolications such as preterm birth or perinatal morbidity. Aerosol transmission based precautions that are commonly used are continued to prevent spread if respiratory support is needed in the delivery room or the NICU. Normal newborn care such as delayed cord clamping, breastfeeding, and rooming-in are considered safe.
GBS is a leading cause of perinatal infections including bacteremia, endometritis, chorioamnionitis, urinary tract infections (UTIs). In the newborn, it can cause focal or systemic disease. GBS commonly lives in the human GI and genitourinary tracts. Colonization during pregnancy can be continuous or intermittent (AAP, 2018). The practice of giving prophylactic antibiotics to women in labor who are GBS positive has significantly reduced the incidence and severity of early-onset GBS infection in the newborn. The incidence of early-onset neonatal GBS infection is 0.25/1000 live births (AAP, 2018). Risk factors for the development of early-onset GBS infection include:
Preterm birth
Rupture of membranes of more than 18 hours before birth
Intrapartum maternal fever (>38° C [100.4° F])
Previous infant with invasive GBS disease
Maternal GBS bacteriuria during the current pregnancy
Intraamniotic infection (chorioamnionitis)
Maternal age less than 20 years old
Intrauterine fetal monitoring
African-American ethnicity
Early-onset disease develops during the first 7 days, most often within 24 hours after birth, and usually results from vertical transmission from the birth canal. It manifests as systemic infection or respiratory illness that mimics the symptoms of severe respiratory distress. Infant can rapidly develop pneumonia, shock, or meningitis. Late-onset GBS infections typically occur from 7 days to 3 months of age. Late-onset infection is associated with meningitis, osteomyelitis, and septic arthritis. The usual treatment is ampicillin in combination with an aminoglycoside. If GBS is identified as the cause of infection, penicillin G alone may be given.
E. coli is the second most common pathogen causing sepsis and meningitis in newborns. It can cause a variety of neonatal infections, such as omphalitis, diarrheal illness, pneumonia, peritonitis, UTI, and meningitis. Risk factors for the development of E. coli infections in the newborn include preterm birth, low birth weight, maternal infection, prolonged rupture of membranes. Usual treatment for E. coli infection is ampicillin or an extended-spectrum cephalosporin and an aminoglycoside.
Most staphylococcal infections in the newborn develop after the first 72 hours of life and involve the skin and soft tissue. Conjunctivitis, presenting with purulent eye discharge, is common manifestation of S. aureus infection. Skin lesions are typically small vesicles or pustules that are easily treated with topical antimicrobial agents. More severe bullous eruption due to staphylococcal infection is scalded skin syndrome characterized by widespread bullous lesions that easily rupture. Fever and irritability are also present. S. aureus can cause serious problems, including abscesses, osteomyelitis, endocarditis, and septic arthritis. Initial treatment includes nafcillin and vancomycin until definitive culture results are available.
Neonatal infection caused by chlamydia trachomatis causes neonatal conjunctivitis. Neonatal chlamydial conjunctivitis, with redness of the eyes, edema of the eyelids, and minimal discharge, develops within a few days to several weeks after birth and usually lasts 1 to 2 weeks. Chlamydial pneumonia usually has a gradual onset, between 2 and 19 weeks of age. Manifestations include tachypnea, otitis media, nasal stuffiness, and coughing. Treated with oral erythromycin or azithromycin.
Screening during pregnancy and universal administration of neonatal eye prophylaxis (0.5% erythromycin ophthalmic ointment) during the first hour after birth have helped reduce the rates of neonatal infection, which occurs during birth when the infant is exposed to the mother’s infected cervix. Infection in the neonate presents 2 to 5 days after birth and most often involves the eyes, causing ophthalmia neonatorum. Infants with systemic gonococcal infection require hospitalization and 7 days of IV antibiotic therapy. If the newborn has gonococcal meningitis, 10 to 14 days of treatment is required.
Syphilis is caused by infection with the spirochete Treponema pallidum. Congenital syphilis can cause severe illness, miscarriage, stillbirth, and early infant death. Clinical manifestations of congenital syphilis can include:
Hepatosplenomegaly
Snuffles
Lymphadenopathy
Mucocutaneous lesions
Pneumonia
Osteochondritis
Pseudoparalysis
Edema
Rash
Hemolytic anemia
Thrombocytopenia
Treatment of the newborn should be initiated when the diagnosis of congenital syphilis is confirmed or suspected or when maternal treatment status is unknown or not well documented. Infants who are symptomatic or whose mother was untreated or unsatisfactorily treated, should have:
Lumbar puncture (to evaluate for neurologic involvement)
CBC
RPR
VDRL
Long-bone radiography prior to treatment
If results of these tests are normal and follow-up is certain, a single intramuscular (IM) dose of penicillin G benzathine is recommended. If results are abnormal or there is concern about appropriate follow-up, a 10-day course of IV aqueous penicillin G or IM penicillin G procaine should be given.
Listeriosis, caused by L. monocytogenes , is primarily a foodborne infection that can cause maternal and neonatal illness. This can cause:
Chorioamnionitis
Endometritis
Miscarriage
Preterm birth
Stillbirth
Manifestations include:
Sepsis-like symptoms
Acute respiratory distress
Pneumonia
Meningitis
Myocarditis
Fungal infections cause great concern in the immunocompromised or premature infant.
Candida infection: yeast-like fungus (producing yeast cells and spores). Newborn with congenital cutaneous candidiasis (CCC) presents with skin lesions, most commonly on the back extensor extremities and in skin creases and folds. Lesions appear as:
Erythematous macules
Papules
Vesicopustules with background erythema
Diaper dermatitis is a common finding of candidiasis. Treatment is an antifungal ointment, such as nystatin (Mycostatin). Oral candidiasis (thrush, or mycotic stomatitis) is characterized by the appearance of white plaques on the oral mucosa, gums, and tongue. Systemic candida infection is usually limited to critically ill neonates receiving antibiotic therapy for bacterial infections or who have indwelling catheters. For these infants, antifungal agents such as amphotericin B (Fungizone) or fluconazole (Diflucan) are given intravenously.
Common ways that humans contract toxoplasmosis include:
Eating raw or undercooked meats or seafoods
Working with meat
Drinking unpasteurized milk
Handling cat litter that contains feces in which the Toxoplasma parasite was shed
Exposure to contaminated soil
Clinical manifestations of toxoplasmosis are often difficult to distinguish from other congenital infections. Approximately one-third of newborns have a generalized form of the disease that involves the reticuloendothelial system. Other two-thirds of infected newborns have neurologic signs. Clinical features are three key findings (classic triad):
Hydrocephalus
Chorioretinitis
Cerebral calcifications
Severe toxoplasmosis is associated with:
Preterm birth
IUGR
Microcephaly
Hydrocephaly
Microphthalmia
Chorioretinitis
CNS calcification
Thrombocytopenia
Jaundice
Fever
Petechiae
Maculopapular rash
Infants with congenital toxoplasmosis are treated with pyrimethamine, combined with oral sulfadiazine; folinic acid supplement is used to prevent anemia.
American Academy of Pediatrics (2022, November 11). FAQs: Management of Infants Born to Mothers with Suspected or Confirmed COVID-19. FAQs: Management of Infants Born to Mothers with Suspected or Confirmed COVID-19 (aap.org)
Long, S.S. (2022). Newborn Infection. Principles and Practice of Pediatric Infectious Diseases. https://www.sciencedirect.com/topics/medicine-and-dentistry/newborn-infection
Singh, M., Alsaleem, M., & Gray, C.P. (2022, September 29). Neonatal Sepsis. NIH StatPearls: https://www.ncbi.nlm.nih.gov/books/NBK531478/